Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
gut microbiota1104 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A06590 | 32816619 | Gut Microbes | Modifying macronutrients is superior to microbiome transplantation in treating nonalcoholic fatty liver disease. | 2020 | Details |
| A06619 | 32805210 | Chem Biol Interact | High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. | 2020 | Details |
| A06627 | 32801462 | J Clin Biochem Nutr | Epigallocatechin-3-gallate (EGCG) attenuates non-alcoholic fatty liver disease via modulating the interaction between gut microbiota and bile acids. | 2020 | Details |
| A06651 | 32794259 | Hepatology | The Commensal Microbe Veillonella as a Marker for Response to an FGF19 Analog in NASH. | 2020 | Details |
| A06661 | 32791115 | Cell Host Microbe | Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future. | 2020 | Details |
| A06663 | 32790577 | Physiol Rev | Molecular Physiology of Bile Acid Signaling in Health, Disease, and Aging. | 2020 | Details |
| A06669 | 32786868 | J Agric Food Chem | Fermented Soy Paste Alleviates Lipid Accumulation in the Liver by Regulating the AMPK Pathway and Modulating Gut Microbiota in High-Fat-Diet-Fed Rats. | 2020 | Details |
| A06677 | 32783933 | Cell Rep | Activation of a Specific Gut Bacteroides-Folate-Liver Axis Benefits for the Alleviation of Nonalcoholic Hepatic Steatosis. | 2020 | Details |
| A06732 | 32766473 | Hepatol Commun | Genome-Wide Association Study of Lean Nonalcoholic Fatty Liver Disease Suggests Human Leukocyte Antigen as a Novel Candidate Locus. | 2020 | Details |
| A06740 | 32764281 | Nutrients | The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases. | 2020 | Details |
| A06756 | 32758573 | Eur J Pharmacol | Gut microbiota modulation as a promising therapy with metformin in rats with non-alcoholic steatohepatitis: Role of LPS/TLR4 and autophagy pathways. | 2020 | Details |
| A06763 | 32756323 | J Clin Med | Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. | 2020 | Details |
| A06810 | 32738185 | Mol Nutr Food Res | The Gut Microbiota and Its Metabolites, Novel Targets for Treating and Preventing Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A06866 | 32717871 | Int J Mol Sci | Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications. | 2020 | Details |
| A06882 | 32711187 | Transl Res | The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet. | 2020 | Details |
| A06909 | 32700545 | Biol Res Nurs | Oral Probiotic Bifidobacterium Longum Supplementation Improves Metabolic Parameters and Alters the Expression of the Renin-Angiotensin System in Obese Mice Liver. | 2020 | Details |
| A06918 | 32698063 | Int J Biol Macromol | Effects of surface-deacetylated chitin nanofibers on non-alcoholic steatohepatitis model rats and their gut microbiota. | 2020 | Details |
| A06932 | 32694791 | Nat Metab | The small intestine shields the liver from fructose-induced steatosis. | 2020 | Details |
| A06936 | 32694178 | Gut | Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. | 2020 | Details |
| A06952 | 32688217 | J Nutr Biochem | Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiota. | 2020 | Details |
| A06961 | 32685936 | Explor Med | Nonalcoholic fatty liver disease and portal hypertension. | 2020 | Details |
| A07050 | 32641615 | J Oleo Sci | Basil Essential Oil and Its Nanoemulsion Mitigate Non Alcoholic Steatohepatitis in Rat Model with Special Reference to Gut Microbiota. | 2020 | Details |
| A07053 | 32640105 | J Intern Med | A systems biology approach to understand gut microbiota and host metabolism in morbid obesity: design of the BARIA Longitudinal Cohort Study. | 2020 | Details |
| A07112 | 32618656 | Am J Gastroenterol | Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial. | 2020 | Details |
| A07192 | 32587515 | Front Pharmacol | Integrated Metagenomic and Metabolomic Analyses of the Effect of Astragalus Polysaccharides on Alleviating High-Fat Diet-Induced Metabolic Disorders. | 2020 | Details |
| A07215 | 32579743 | Mol Nutr Food Res | Fat-Shaped Microbiota Affects Lipid Metabolism, Liver Steatosis, and Intestinal Homeostasis in Mice Fed a Low-Protein Diet. | 2020 | Details |
| A07230 | 32573567 | Food Funct | Bifidobacterium adolescentis and Lactobacillus rhamnosus alleviate non-alcoholic fatty liver disease induced by a high-fat, high-cholesterol diet through modulation of different gut microbiota-dependent pathways. | 2020 | Details |
| A07265 | 32561908 | J Clin Endocrinol Metab | Effect of Gut Microbiota and PNPLA3 rs738409 Variant on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Youth. | 2020 | Details |
| A07320 | 32540565 | Environ Pollut | Bisphenol A exposure induces gut microbiota dysbiosis and consequent activation of gut-liver axis leading to hepatic steatosis in CD-1 mice. | 2020 | Details |
| A07326 | 32536582 | Clin Nutr | Impact of short-term overfeeding of saturated or unsaturated fat or sugars on the gut microbiota in relation to liver fat in obese and overweight adults. | 2020 | Details |
| A07340 | 32531370 | Int J Biol Macromol | The protective effects of walnut green husk polysaccharide on liver injury, vascular endothelial dysfunction and disorder of gut microbiota in high fructose-induced mice. | 2020 | Details |
| A07357 | 32526796 | Mol Nutr Food Res | Dietary Fiber from Oat and Rye Brans Ameliorate Western Diet-Induced Body Weight Gain and Hepatic Inflammation by the Modulation of Short-Chain Fatty Acids, Bile Acids, and Tryptophan Metabolism. | 2020 | Details |
| A07373 | 32523101 | Sci Rep | Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive tools. | 2020 | Details |
| A07375 | 32522273 | Trials | Traditional Chinese medicine Lingguizhugan decoction treating non-alcoholic fatty liver disease with spleen-yang deficiency pattern: Study protocol for a multicenter randomized controlled trial. | 2020 | Details |
| A07387 | 32518225 | Nutr Diabetes | Consumption of a high energy density diet triggers microbiota dysbiosis, hepatic lipidosis, and microglia activation in the nucleus of the solitary tract in rats. | 2020 | Details |
| A07392 | 32516028 | Am J Physiol Endocrinol Metab | NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice. | 2020 | Details |
| A07408 | 32512581 | PLoS One | Polysaccharides isolated from Cordyceps Sinensis contribute to the progression of NASH by modifying the gut microbiota in mice fed a high-fat diet. | 2020 | Details |
| A07426 | 32504921 | Biomed Pharmacother | The influence of probiotics on bile acids in diseases and aging. | 2020 | Details |
| A07451 | 32490750 | Physiology (Bethesda) | Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know? | 2020 | Details |
| A07471 | 32483129 | Sci Rep | Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2020 | Details |
| A07486 | 32476787 | World J Gastroenterol | Folic acid attenuates high-fat diet-induced steatohepatitis via deacetylase SIRT1-dependent restoration of PPARα. | 2020 | Details |
| A07581 | 32436410 | Nutr Cancer | Combined Amelioration of Prebiotic Resveratrol and Probiotic Bifidobacteria on Obesity and Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07622 | 32417163 | Chem Biol Interact | Potential role of gut microbiota, the proto-oncogene PIKE (Agap2) and cytochrome P450 CYP2W1 in promotion of liver cancer by alcoholic and nonalcoholic fatty liver disease and protection by dietary soy protein. | 2020 | Details |
| A07681 | 32392712 | J Clin Med | A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression. | 2020 | Details |
| A07686 | 32390701 | World J Gastroenterol | Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view. | 2020 | Details |
| A07689 | 32390455 | Antioxid Redox Signal | Intestinal Dysbiosis and Development of Cardiometabolic Disorders in Childhood Cancer Survivors: A Critical Review. | 2020 | Details |
| A07697 | 32388250 | J Nutr Biochem | Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis. | 2020 | Details |
| A07757 | 32363319 | Hepatol Commun | High Protein Intake Is Associated With Histological Disease Activity in Patients With NAFLD. | 2020 | Details |
| A07776 | 32357561 | Int J Mol Sci | The Molecular and Mechanistic Insights Based on Gut-Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement. | 2020 | Details |
| A07797 | 32352707 | Clin Transl Gastroenterol | Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC. | 2020 | Details |
| A07846 | 32336663 | Surg Obes Relat Dis | Is bariatric surgery resolving NAFLD via microbiota-mediated bile acid ratio reversal? A comprehensive review. | 2020 | Details |
| A07850 | 32335723 | Appl Microbiol Biotechnol | Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation. | 2020 | Details |
| A07880 | 32325178 | J Ethnopharmacol | Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice. | 2020 | Details |
| A07883 | 32323426 | Hepatol Res | Omics-derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseases. | 2020 | Details |
| A07885 | 32323179 | Adv Exp Med Biol | Gut Microbiota and Liver Injury (II): Chronic Liver Injury. | 2020 | Details |
| A07907 | 32315005 | Food Funct | Alleviating effects of noni fruit polysaccharide on hepatic oxidative stress and inflammation in rats under a high-fat diet and its possible mechanisms. | 2020 | Details |
| A07978 | 32291578 | Indian J Gastroenterol | Gut microbiota abnormalities, small intestinal bacterial overgrowth, and non-alcoholic fatty liver disease: An emerging paradigm. | 2020 | Details |
| A08054 | 32267559 | J Gastroenterol Hepatol | Phenotyping non-alcoholic fatty liver disease by the gut microbiota: Ready for prime time? | 2020 | Details |
| A08078 | 32256270 | EXCLI J | Short term effects of coffee components consumption on gut microbiota in patients with non-alcoholic fatty liver and diabetes: A pilot randomized placebo-controlled, clinical trial. | 2020 | Details |
| A08105 | 32245128 | Nutrients | Increase of Akkermansia muciniphila by a Diet Containing Japanese Traditional Medicine Bofutsushosan in a Mouse Model of Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A08109 | 32244182 | Mol Metab | Impact of global PTP1B deficiency on the gut barrier permeability during NASH in mice. | 2020 | Details |
| A08111 | 32243703 | Liver Int | Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A08144 | 32230953 | Nutrients | Inflammation in Primary and Metastatic Liver Tumorigenesis-Under the Influence of Alcohol and High-Fat Diets. | 2020 | Details |
| A08150 | 32228300 | Gut Microbes | Maternal sucralose intake alters gut microbiota of offspring and exacerbates hepatic steatosis in adulthood. | 2020 | Details |
| A08178 | 32217466 | J Nutr Biochem | The modulation of Luffa cylindrica (L.) Roem supplementation on gene expression and amino acid profiles in liver for alleviating hepatic steatosis via gut microbiota in high-fat diet-fed mice: insight from hepatic transcriptome analysis. | 2020 | Details |
| A08186 | 32214246 | Nature | Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate. | 2020 | Details |
| A08209 | 32204538 | Nutrients | Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan. | 2020 | Details |
| A08298 | 32163832 | J Nutr Biochem | Housing condition-associated changes in gut microbiota further affect the host response to diet-induced nonalcoholic fatty liver. | 2020 | Details |
| A08313 | 32156377 | Food Res Int | Effect of okra fruit powder supplementation on metabolic syndrome and gut microbiota diversity in high fat diet-induced obese mice. | 2019 | Details |
| A08325 | 32152478 | Nat Rev Gastroenterol Hepatol | Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. | 2020 | Details |
| A08337 | 32149099 | Biomed Res Int | Liraglutide Attenuates Nonalcoholic Fatty Liver Disease by Modulating Gut Microbiota in Rats Administered a High-Fat Diet. | 2020 | Details |
| A08566 | 32059982 | J Hepatol | NAFLD as a driver of chronic kidney disease. | 2020 | Details |
| A08601 | 32044317 | Gastroenterology | Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity? | 2020 | Details |
| A08635 | 32037512 | Br J Pharmacol | P7C3-A20 alleviates fatty liver by shaping gut microbiota and inducing FGF21/FGF1, via the AMP-activated protein kinase/CREB regulated transcription coactivator 2 pathway. | 2020 | Details |
| A08638 | 32036510 | Dig Dis Sci | Omega-3 Fatty Acids and Gut Microbiota: A Reciprocal Interaction in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08655 | 32031871 | Am J Physiol Heart Circ Physiol | Gut microbiome of a porcine model of metabolic syndrome and HF-pEF. | 2020 | Details |
| A08681 | 32024509 | BMC Complement Med Ther | Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats. | 2020 | Details |
| A08696 | 32019793 | mBio | Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08741 | 32004929 | J Nutr Biochem | Advanced liver steatosis accompanies an increase in hepatic inflammation, colonic, secondary bile acids and Lactobacillaceae/Lachnospiraceae bacteria in C57BL/6 mice fed a high-fat diet. | 2020 | Details |
| A08760 | 31998283 | Front Immunol | Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice. | 2020 | Details |
| A08782 | 31986416 | Biomed Pharmacother | Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis. | 2020 | Details |
| A08788 | 31984787 | Am J Physiol Gastrointest Liver Physiol | Vitamin D signaling maintains intestinal innate immunity and gut microbiota: potential intervention for metabolic syndrome and NAFLD. | 2020 | Details |
| A08818 | 31979147 | Nutrients | The Effects of Gelatinized Wheat Starch and High Salt Diet on Gut Microbiota and Metabolic Disorder. | 2020 | Details |
| A08832 | 31973214 | Nutrients | Murine Genetic Background Overcomes Gut Microbiota Changes to Explain Metabolic Response to High-Fat Diet. | 2020 | Details |
| A08842 | 31969089 | Curr Pharm Des | NAFLD at the Interface of the Mother-Infant Dyad. | 2020 | Details |
| A08867 | 31956961 | Diabetes Ther | Study Protocol for Pleiotropic Effects and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Versus Sulfonylurea in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08882 | 31953338 | Appl Environ Microbiol | Akkermansia muciniphila Prevents Fatty Liver Disease, Decreases Serum Triglycerides, and Maintains Gut Homeostasis. | 2020 | Details |
| A08891 | 31950772 | Diabetes Metab J | Combination of Probiotics and Salvia miltiorrhiza Polysaccharide Alleviates Hepatic Steatosis via Gut Microbiota Modulation and Insulin Resistance Improvement in High Fat-Induced NAFLD Mice. | 2019 | Details |
| A08919 | 31937803 | Sci Rep | Integrative analysis of blood and gut microbiota data suggests a non-alcoholic fatty liver disease (NAFLD)-related disorder in French SLAdd minipigs. | 2020 | Details |
| A08923 | 31936799 | Cells | Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis. | 2020 | Details |
| A08969 | 31921729 | Front Pediatr | Metagenome of Gut Microbiota of Children With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A08984 | 31915606 | J Clin Transl Hepatol | Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A08996 | 31910634 | Arch Iran Med | Fecal Microbiota in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Systematic Review. | 2020 | Details |
| A09057 | 34350368 | Cardiol Plus | Bile Acid and Cholesterol Metabolism in Atherosclerotic Cardiovascular Disease and Therapy. | 2020 | Details |
| A09086 | 31881272 | Pharmacol Res | The gut-liver-kidney axis: Novel regulator of fatty liver associated chronic kidney disease. | 2019 | Details |
| A09179 | 31846961 | Lifestyle Genom | One-Carbon Metabolism and Nonalcoholic Fatty Liver Disease: The Crosstalk between Nutrients, Microbiota, and Genetics. | 2019 | Details |
| A09195 | 31840358 | Hepatol Res | Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives. | 2020 | Details |
| A09227 | 31828683 | Eur J Clin Microbiol Infect Dis | Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies. | 2019 | Details |
| A09314 | 31793675 | J Food Biochem | Ganoderma polysaccharide and chitosan synergistically ameliorate lipid metabolic disorders and modulate gut microbiota composition in high fat diet-fed golden hamsters. | 2019 | Details |
| A09316 | 31793324 | Nutr Hosp | Immunonutritional contribution of gut microbiota to fatty liver disease. | 2020 | Details |